The Complainant is Elsevier BV, Netherlands, represented by Nelson Mullins Riley & Scarborough, L.L.P., United States of America (“United States”).
The Respondent1 is Noureddine Ayoub, Morocco; and Domains by Proxy, LLC, United States / Name Redacted.2
2. The Domain Names and RegistrarThe disputed domain names
The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on November 9, 2021. On November 10, 2021, the Center transmitted by email to the Registrar a request for registrar verification in connection with the disputed domain names. On November 10, 2021, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the disputed domain names which differed from the named Respondent and contact information in the Complaint. The Center sent an email communication to the Complainant on November 12, 2021, providing the registrant and contact information disclosed by the Registrar, and inviting the Complainant to submit an amendment to the Complaint. The Complainant filed an amended Complaint on November 16, 2021. On the same date, the Center received an email from the named registrant of the disputed domain name
The Center verified that the Complaint together with the amended Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).
In accordance with the Rules, paragraphs 2 and 4, the Center formally notified the Respondent of the Complaint, and the proceedings commenced on December 8, 2021. In accordance with the Rules, paragraph 5, the due date for Response was December 28, 2021. The Respondent did not submit any formal response. Accordingly, the Center informed the Parties that it would proceed with panel appointment on January 10, 2022.
The Center appointed Adam Taylor as the sole panelist in this matter on January 20, 2022. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7.
The Center received an email from the named registrant of the disputed domain names
The Complainant is a publishing company, specialising in scientific, technical, and medical content.
Since 2004, the Complainant and its predecessors have operated an “abstract and citation” database called “Scopus” that comprises some 75 million records in the fields of life, social, physical and health sciences.
The Complainant owns a number of registered trade marks for SCOPUS including United States trade mark No. 2,952,563, filed on March 3, 2003, registered on May 17, 2005, in class 42.
The Complainant promotes its Scopus database via a website at “www.scopus.com”.
The disputed domain names
As of November 8, 2021, the disputed domain names
So far as the Panel is aware, the disputed domain name
The Complainant sent cease and desist emails to the Respondent on September 7 and 30, 2021. The Respondent did not reply.
5. Parties’ Contentions A. ComplainantThe following is a summary of the Complainant’s contentions.
The Complainant’s trade mark has become well known as a result of the Complainant’s long, continuous and extensive worldwide use thereof.
The disputed domain names are confusingly similar to the Complainant’s trade mark as they consist of that mark together with the descriptive word “journals”, which is a term directly associated with the Complainant’s business.
The Respondent has no rights or legitimate interests in respect of the disputed domain names.
The Complainant has not authorised the Respondent to use its mark.
The Respondent is not commonly known by the disputed domain names.
Nor has the Respondent used the disputed domain name for a bona fide offering of goods or services but, rather, in a manner that created the impression that its websites were authorised by the Complainant in order to derive financial gain from the goodwill associated with the Complainant’s mark.
The Respondent is not making a legitimate noncommercial use of the disputed domain names. Its purpose is clearly commercial.
The disputed domain names were registered and are being used in bad faith.
The Respondent was clearly aware of the Complainant’s rights in its mark but nonetheless registered and used the disputed domain names, which included the Complainant’s distinctive mark plus the term “journals”, for websites offering services closely related to those of the Complainant in order to create a likelihood of confusion with the Complainant’s mark as well as to disrupt a competitor.
The Respondent’s failure to respond to the Complainant’s cease and desist emails is further evidence of bad faith.
B. RespondentOn November 16, 2021, the Center received an email communication from the named registrant of the disputed domain name
On February 16, 2022, the Center received an email from the named registrant of the disputed domain names
The Respondent did not formally reply to the Complainant’s contentions.
6. Discussion and FindingsUnder the Policy, the Complainant is required to prove on the balance of probabilities that:
- the disputed domain names are identical or confusingly similar to a trade mark in which the Complainant has rights;
- the Respondent has no rights or legitimate interests in respect of the disputed domain names; and
- the disputed domain names have been registered and are being used in bad faith.
The principles governing the question of whether a complaint may be brought against multiple respondents are set out in section 4.11 of the WIPO Overview of WIPO Panel Views on Selected UDRP Questions, Third Edition (“WIPO Overview 3.0”).
It is clear that the disputed domain names
The position regarding the disputed domain name
On the other hand, this disputed domain name follows exactly the format of the other disputed domain names, i.e., combining the distinctive term “scopus” with the descriptive word “journals”. Furthermore, not only has the owner of this disputed domain name not denied an association with the other disputed domain names but, as explained above, the person named as registrant of
In these circumstances, the Panel considers it reasonable to infer that the disputed domain name
The Complainant has established rights in the mark SCOPUS by virtue of its registered trade marks as well as unregistered trade mark rights deriving from its extensive and longstanding use of that mark for the purposes of the Policy.
Section 1.8 of the WIPO Overview 3.0 makes clear that, where the relevant trade mark is recognisable within the disputed domain name, the addition of other terms, whether descriptive or otherwise, would not prevent a finding of confusing similarity under the first element. Here, the Complainant’s distinctive trade mark is readily recognisable within the disputed domain names and, accordingly, the addition of the descriptive term “journals” does not prevent a finding of confusing similarity.
For the above reasons, the Panel concludes that the disputed domain names are confusingly similar to the Complainant’s trade mark and that the Complainant has therefore established the first element of paragraph 4(a) of the Policy.
C. Rights or Legitimate InterestsAs explained in section 2.1 of the WIPO Overview 3.0, the consensus view is that, where a complainant makes out a prima facie case that the respondent lacks rights or legitimate interests, the burden of production shifts to the respondent to come forward with relevant evidence demonstrating rights or legitimate interests in the domain name. If not, the complainant is deemed to have satisfied the second element.
Here, the Complainant has not licensed or otherwise authorised the Respondent to use its trade mark.
Paragraph 4(c) of the Policy gives examples of circumstances which, if proved, suffice to demonstrate that a respondent possesses rights or legitimate interests.
As to paragraph 4(c)(i) of the Policy, there is no evidence of any use of the disputed domain name
As regards disputed domain names
Nor is there any evidence that paragraphs 4(c)(ii) or (iii) of the Policy apply in the circumstances of this case.
The Panel finds that the Complainant has established a prima facie case of lack of rights or legitimate interests and there is no rebuttal by the Respondent.
For the above reasons, the Panel concludes that the Complainant has established the second element of paragraph 4(a) of the Policy.
D. Registered and Used in Bad FaithIn the Panel’s view, paragraph 4(b)(iv) of the Policy applies to the disputed domain names
As regards the disputed domain name
The Complainant has therefore established the third element of paragraph 4(a) of the Policy.
7. DecisionFor the foregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the disputed domain names,
Adam Taylor
Sole Panelist
Date: February 23, 2022
1 For reasons explained in section 6A below, the Panel will refer to the Respondents collectively as “the Respondent” unless it is necessary to refer to them separately.
2 The underlying controller of the disputed domain name